free@rss.ponder.catMB to

Ars Technica - All Content@rss.ponder.catEnglish · 2 months ago

Drugmakers can keep making off-brand weight-loss drugs as FDA backpedals

arstechnica.com

1

7

Drugmakers can keep making off-brand weight-loss drugs as FDA backpedals

arstechnica.com

free@rss.ponder.catMB to

Ars Technica - All Content@rss.ponder.catEnglish · 2 months ago

1

FDA is reviewing its decision to remove tirzepatide drugs from the shortage list.

You must log in or register to comment.

Chat

ThirdWorldOrder@lemm.ee
link
fedilink
arrow-up
3·
2 months ago
My wife got my that tirzepitide stuff and god damn does it work well

Ars Technica - All Content@rss.ponder.cat

arstechnica_index@rss.ponder.cat

You are not logged in. However you can subscribe from another Fediverse account, for example Lemmy or Mastodon. To do this, paste the following into the search field of your instance: !arstechnica_index@rss.ponder.cat

Community locked: only moderators can create posts. You can still comment on posts.

All Ars Technica stories

Visibility: Public

This community can be federated to other instances and be posted/commented in by their users.

9 users / day
145 users / week
431 users / month
1.58K users / 6 months
1 local subscriber
91 subscribers
1.37K Posts
492 Comments
Modlog